WntRx Pharmaceuticals' Incubator/Accelerator Round

WntRx Pharmaceuticals raised a round of funding on February 24, 2016. Investors include MassCONNECT.

WntRx Pharmaceuticals focuses on early stage research and development of cancer drugs. The company is developing a first-in-class oncogenic specific Wnt pathway inhibitor for colorectal cancer patient…

Articles about WntRx Pharmaceuticals' Incubator/Accelerator Round: